
August 29, 2008
New technology at St. Luke’s is allowing doctors to improve treatment for patients suffering from abnormal heart rhythms.
Arrhythmias, or electrical problems of the heart, affect millions of people each year.
One of those electrical problems is called atrial fibrillation (AF). According to the Centers for Disease Control (CDC), AF is the most common sustained heart rhythm disorder in the United States. It increases the risk for heart disease and stroke, both leading causes of death in the U.S. An estimated two million adults have been diagnosed with atrial fibrillation.
AF is a complex arrhythmia in which the atria or upper chambers of the heart beat rapidly and never adequately fill the ventricles or lower chambers with blood. This results in inadequate blood flow to the body and may lead to stroke as the blood left in the atria pools and forms clots that can dislodge and travel to the brain. According to the American College of Cardiology (ACC) approximately 75,000 strokes occur each year as a result of AF and these numbers continue to escalate as the population grows older.
In July, St. Luke’s acquired the Hansen Sensei Robotic Catheter System, which allows doctors to treat heart rhythm disorders, like AF with greater precision.
“The Hansen Sensei Robot helps map the heart and acts as a guide to find the spot where the abnormal heart rhythm is coming from,” said Mohit Chawla, MD, Cardiologists, PC. “When I find the problem area, energy is used to disrupt those circuits and correct the problem. The robotic arm gives me more control and accuracy over the catheter, which is inserted into the patient’s veins to target areas in the heart.”
“This navigational robotic arm allows more precise movement and localization of the catheter,” said Todd Langager, MD, Cardiologists, PC and medical director of St. Luke’s electrophysiology (EP) Lab. “It improves the catheter stability and in time it should shorten the procedure length, which is beneficial to the patient.”
The Sensei robot is not performing the procedure; the doctor is manipulating the catheter with a joystick from a remote work station. Not only does the robot give doctors greater accuracy and control but it also prevents fatigue, which allows them to perform more procedures.
The Hansen Sensei Robotic Catheter System gained U.S. Food and Drug Administration (FDA) approval in May 2007. Manufactured by Hansen Medical in California, the device is a relative of sorts to the da Vinci surgical robot, which is manufactured by Intuitive Surgical. St. Luke’s has two da Vinci robots, which are used in a variety of urological and gynecological surgeries. Intuitive was founded by the same doctor that is now the chief executive of Hansen Medical.
“St. Luke’s is the only hospital in the state with this technology,” said Dr. Langager. “It is state-of-the-art. We are particularly proud here at St. Luke’s that we are the first in Iowa to use the Hansen Sensei Robot.”
In fact, only 40 hospitals in the world have this technology. In the Midwest, the closest hospitals with the Hansen Sensei Robot are in Chicago and Milwaukee.
“Eventually more hospitals will acquire this technology because it’s the future,” said Dr. Chawla. “Having the Hansen Sensei Robot is a big deal for Cedar Rapids. It’s going to offer patients a procedure with accuracy that they can’t find anywhere else in the state.”
MEDIA CONTACT: Sarah Corizzo, St. Luke’s Hospital, 319/369-8372 or 319/560-2385.